UGE vs. CURE

Last updated Jun 13, 2026

UGE (ProShares Ultra Consumer Goods) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - UGE tracks the Dow Jones U.S. Consumer Goods Index (200%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, UGE returned 8.80%/yr vs 13.49%/yr for CURE. A 0.53 correlation means they provide meaningful diversification when combined. UGE charges 0.95%/yr vs 1.08%/yr for CURE.

Performance

UGE vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Consumer Goods (UGE) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UGE achieves a 18.88% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, UGE has underperformed CURE with an annualized return of 8.80%, while CURE has yielded a comparatively higher 13.49% annualized return.

UGE

• 1D: 1.08%
• 1M: 1.97%
• YTD: 18.88%
• 6M: 15.24%
• 1Y: 7.12%
• 3Y*: 7.90%
• 5Y*: -1.08%
• 10Y*: 8.80%

CURE

• 1D: -0.55%
• 1M: 13.53%
• YTD: -7.96%
• 6M: -6.00%
• 1Y: 26.46%
• 3Y*: 3.05%
• 5Y*: 1.51%
• 10Y*: 13.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UGE vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UGE ProShares Ultra Consumer Goods	18.88%	-5.21%	16.40%	2.38%	-46.78%	42.44%	56.64%	58.28%	-30.14%	32.38%
CURE Direxion Daily Healthcare Bull 3x Shares	-7.96%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Correlation

The correlation between UGE and CURE is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.37
Correlation (3Y) Calculated over the trailing 3-year period	0.49
Correlation (5Y) Calculated over the trailing 5-year period	0.54
Correlation (10Y) Calculated over the trailing 10-year period	0.54
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011	0.53

The correlation between UGE and CURE shifts across timeframes, from 0.37 (1 year) to 0.54 (10 years), reflecting how their relationship changes across market environments.

UGE vs. CURE - Sectors Allocation Comparison

Sectors	UGE	CURE
Consumer Defensive	99.0%	-
Consumer Cyclical	1.0%	-
Basic Materials	-	-
Communication Services	-	-
Energy	-	-
Financial Services	-	-
Healthcare	-	100.0%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

UGE vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UGE

UGE Risk / Return Rank: 14
UGE Sharpe Ratio Rank: 14
UGE Sortino Ratio Rank: 14
UGE Omega Ratio Rank: 14
UGE Calmar Ratio Rank: 14
UGE Martin Ratio Rank: 13

CURE

CURE Risk / Return Rank: 21
CURE Sharpe Ratio Rank: 20
CURE Sortino Ratio Rank: 24
CURE Omega Ratio Rank: 22
CURE Calmar Ratio Rank: 22
CURE Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UGE vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Consumer Goods (UGE) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UGE	CURE	Difference
Sharpe ratio: Return per unit of total volatility	0.28	0.60	-0.32
Sortino ratio: Return per unit of downside risk	0.58	1.18	-0.60
Omega ratio: Gain probability vs. loss probability	1.07	1.13	-0.06
Calmar ratio: Return relative to maximum drawdown	0.38	0.85	-0.48
Martin ratio: Return relative to average drawdown	0.67	1.94	-1.27

UGE vs. CURE - Sharpe Ratio Comparison

The current UGE Sharpe Ratio is 0.28, which is lower than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of UGE and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UGE vs. CURE - Drawdown Comparison

The maximum UGE drawdown since its inception was -71.36%, roughly equal to the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UGE and CURE.

Drawdown Indicators

	UGE	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-71.36%	-69.19%	-2.17%
Max Drawdown (1Y) Largest decline over 1 year	-18.95%	-31.10%	+12.15%
Max Drawdown (3Y) Largest decline over 3 years	-24.80%	-51.93%	+27.13%
Max Drawdown (5Y) Largest decline over 5 years	-56.55%	-52.23%	-4.32%
Max Drawdown (10Y) Largest decline over 10 years	-57.14%	-69.19%	+12.05%
Current Drawdown Current decline from peak	-32.84%	-26.94%	-5.90%
Average Drawdown Average peak-to-trough decline	-18.75%	-18.16%	-0.59%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.64%	13.71%	-3.07%

Volatility

UGE vs. CURE - Volatility Comparison

The current volatility for ProShares Ultra Consumer Goods (UGE) is 8.67%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that UGE experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UGE	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.67%	14.30%	-5.63%
Volatility (6M) Calculated over the trailing 6-month period	20.01%	30.87%	-10.86%
Volatility (1Y) Calculated over the trailing 1-year period	25.39%	44.32%	-18.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.37%	43.84%	-12.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.11%	49.59%	-16.48%

UGE vs. CURE - Expense Ratio Comparison

UGE has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.

Dividends

UGE vs. CURE - Dividend Comparison

UGE's dividend yield for the trailing twelve months is around 2.05%, more than CURE's 1.16% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.16%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
UGE ProShares Ultra Consumer Goods	2.05%	2.54%	1.43%	1.20%	0.74%	0.20%	0.41%	0.86%	0.76%	0.68%	0.76%	0.60%

Frequently Asked Questions

Can I hold both UGE and CURE in my portfolio?

UGE and CURE have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UGE or CURE?

CURE has higher volatility (14.30%) compared to UGE (8.67%). In terms of maximum drawdown, UGE dropped -71.36% vs CURE's -69.19%.

Which ETF is better, UGE or CURE?

On 10-year performance, CURE leads with 13.49% vs 8.80% for UGE. On fees, UGE is cheaper at 0.95% per year. On volatility, UGE has been the lower-risk option at 8.67%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, UGE or CURE?

Over the 10-year period, CURE has performed better with a 13.49% return vs 8.80%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, UGE or CURE?

UGE is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, UGE or CURE?

UGE has the higher dividend yield at 2.05%, compared with 1.16% for CURE.

What is the main difference between UGE and CURE?

UGE tracks Dow Jones U.S. Consumer Goods Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UGE and 1.08% for CURE.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.60 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.